Related Experiment Videos
[Systemic lupus erythematosus and pregnancy]
1Revmatologisk avdeling Haukeland sykehus, Bergen.
Summary
Pregnancy in women with systemic lupus erythematosus (SLE) in remission is safe for mother and baby. SLE remission is maintained during pregnancy, with management strategies for flares and postpartum risks.
Area of Science:
- Rheumatology
- Obstetrics
- Immunology
Context:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Pregnancy in SLE patients requires careful management.
- Remission in SLE offers a favorable prognosis during pregnancy.
Purpose:
- To evaluate the maternal and fetal outcomes of pregnancy in SLE patients in remission.
- To assess the impact of pregnancy on SLE disease activity.
- To provide guidance on managing SLE during and after pregnancy.
Summary:
- Pregnancy in SLE patients in remission generally has a good prognosis for both mother and fetus.
- Disease activity in SLE does not worsen short-term or long-term due to pregnancy.
- Immuno-regulatory drugs should be continued; flares can be managed with steroids/azathioprine.
- Postpartum flares are common and can be prevented with steroids.
- Fetal loss risk is high, especially with antiphospholipid antibodies; low-dose aspirin is recommended.
- Neonatal lupus and congenital heart block are rare complications associated with anti-SSA/anti-SSB antibodies.
Impact:
- Informs clinical practice for managing pregnant SLE patients.
- Highlights the safety of continuing immunosuppressants during pregnancy.
- Emphasizes risk stratification and targeted interventions for high-risk pregnancies.
- Reduces maternal and fetal morbidity associated with SLE during pregnancy.